[go: up one dir, main page]

CA2035900A1 - Protein having urate oxidase activity, recombinant gene coding for this protein, expression vector, microorganisms and transformed cells - Google Patents

Protein having urate oxidase activity, recombinant gene coding for this protein, expression vector, microorganisms and transformed cells

Info

Publication number
CA2035900A1
CA2035900A1 CA2035900A CA2035900A CA2035900A1 CA 2035900 A1 CA2035900 A1 CA 2035900A1 CA 2035900 A CA2035900 A CA 2035900A CA 2035900 A CA2035900 A CA 2035900A CA 2035900 A1 CA2035900 A1 CA 2035900A1
Authority
CA
Canada
Prior art keywords
protein
microorganisms
oxidase activity
expression vector
urate oxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2035900A
Other languages
French (fr)
Other versions
CA2035900C (en
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Richard Legoux
Gerard Loison
Elisabeth Larbre
Johannes Lupker
Pascal Leplatois
Marc Salome
Patrick Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8909550A external-priority patent/FR2649720A1/en
Priority claimed from FR8917466A external-priority patent/FR2656530B1/en
Application filed by Individual filed Critical Individual
Publication of CA2035900A1 publication Critical patent/CA2035900A1/en
Application granted granted Critical
Publication of CA2035900C publication Critical patent/CA2035900C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

Abstract

The invention concerns a new urate oxidase activity protein which has the sequence (I), possibly preceeded by a methionine, or in that it may present a degree of substantial homology with this sequence. The invention is also aimed at medicines containing this protein, as well as the genetic engineering implements to obtain it.
CA002035900A 1989-07-13 1990-07-13 Protein having urate oxidase activity, recombinant gene coding for this protein, expression vector, microorganisms and transformed cells Expired - Lifetime CA2035900C (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
FR8909550 1989-07-13
FR8909550A FR2649720A1 (en) 1989-07-13 1989-07-13 Recombinant gene which encodes a protein such as urate oxidase
FR8917466 1989-12-29
FR8917466A FR2656530B1 (en) 1989-12-29 1989-12-29 RECOMBINANT GENE FOR EXPRESSION IN EUKARYOTIC CELLS OF A PROTEIN SUCH AS URATE OXIDASE.
FR9001368 1990-02-06
FR9001368A FR2657785A2 (en) 1989-12-29 1990-02-06 Recombinant gene for expression of a protein such as urate oxidase in animal cells
PCT/FR1990/000532 WO1991000909A1 (en) 1989-07-13 1990-07-13 Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells

Publications (2)

Publication Number Publication Date
CA2035900A1 true CA2035900A1 (en) 1991-01-14
CA2035900C CA2035900C (en) 2000-01-11

Family

ID=27251947

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002035900A Expired - Lifetime CA2035900C (en) 1989-07-13 1990-07-13 Protein having urate oxidase activity, recombinant gene coding for this protein, expression vector, microorganisms and transformed cells

Country Status (23)

Country Link
EP (1) EP0408461B1 (en)
JP (1) JP2664804B2 (en)
AT (1) ATE144282T1 (en)
AU (1) AU636637B2 (en)
BR (1) BR9006855A (en)
CA (1) CA2035900C (en)
DE (2) DE69028884T2 (en)
DK (1) DK0408461T3 (en)
ES (1) ES2095243T3 (en)
FI (1) FI105047B (en)
GR (1) GR3022085T3 (en)
HU (1) HU215948B (en)
IE (1) IE77158B1 (en)
IL (1) IL95057A (en)
LU (1) LU90781I2 (en)
LV (1) LV12000B (en)
MC (1) MC2145A1 (en)
NL (1) NL300046I2 (en)
NO (1) NO2001018I2 (en)
NZ (1) NZ234453A (en)
PT (1) PT94680B (en)
RU (1) RU2105812C1 (en)
WO (1) WO1991000909A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2971218B2 (en) * 1991-12-04 1999-11-02 協和醗酵工業株式会社 Uricase gene and method for producing uricase
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
PL190041B1 (en) * 1996-09-13 2005-10-31 Transkaryotic Therapies Therapy against alpha-galactosidase a deficiency
HU226294B1 (en) * 1998-08-06 2008-08-28 Mountain View Pharmaceuticals Peg-urate oxidase conjugates and use thereof
CA2728907C (en) 1998-08-06 2015-11-24 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
EP1310560A4 (en) 2000-08-17 2005-07-13 Ajinomoto Kk Method of modifying microorganism-origin transglutaminase
NZ536361A (en) 2002-04-25 2008-05-30 Shire Human Genetic Therapies Treatment of alpha-galactosidase a deficiency
PT3321359T (en) 2005-04-11 2021-03-11 Horizon Pharma Rheumatology Llc Variant forms of urate oxidase and use thereof
TWI418564B (en) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc Purification of proteins with cationic surfactant
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
RU2435847C2 (en) 2005-04-11 2011-12-10 Савиент Фармасьютикалз, Инк. Version form urate-oxydase and its use
KR101288027B1 (en) * 2006-04-12 2013-07-22 새비언트 파마수티컬즈 인크. Purification of proteins with cationic surfactant
RU2443426C2 (en) * 2008-11-07 2012-02-27 Мунтэн Вью Фармасьютикэлз, Инк. Urate oxidase conjugates, pharmaceutical composition for reduction in uric acid levels and method for preparing conjugates stated above
EP2446260B1 (en) 2009-06-25 2018-12-26 Horizon Pharma Rheumatology LLC Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
JP2019535819A (en) 2016-11-11 2019-12-12 ホライゾン ファーマ リューマトロジー リミテッド ライアビリティ カンパニーＨｏｒｉｚｏｎ Ｐｈａｒｍａ Ｒｈｅｕｍａｔｏｌｏｇｙ Ｌｌｃ Combination therapy and use of prednisone and uricase molecules
CN109223707B (en) * 2018-09-13 2020-12-08 中国药科大学 A kind of uricase gel preparation for external use, its preparation method and use
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6301M (en) * 1967-03-29 1968-09-09
SU457723A1 (en) * 1973-04-09 1977-08-05 Всесоюзный Научно-Исследовательский Витаминный Институт Strain 313-152 actinomyces sp.as producer of uratoxydase
EP0173378B1 (en) * 1984-07-27 1991-06-12 Unilever N.V. Process for preparing a polypeptide by culturing a transformed microorganism, a transformed microorganism suitable therefor and dna sequences suitable for preparing such microorganism
WO1988008450A1 (en) * 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JPH0671428B2 (en) * 1988-08-17 1994-09-14 サッポロビール株式会社 Uricase DNA sequence and process

Also Published As

Publication number Publication date
JP2664804B2 (en) 1997-10-22
FI911212A0 (en) 1991-03-12
IE902559A1 (en) 1991-02-27
DE10199042I2 (en) 2003-10-23
ATE144282T1 (en) 1996-11-15
NZ234453A (en) 1993-01-27
HK1000099A1 (en) 1997-11-21
DK0408461T3 (en) 1997-03-24
DE10199042I1 (en) 2002-01-10
ES2095243T3 (en) 1997-02-16
LU90781I2 (en) 2001-07-23
IE77158B1 (en) 1997-12-03
EP0408461A1 (en) 1991-01-16
BR9006855A (en) 1991-08-06
DE69028884T2 (en) 1997-05-07
EP0408461B1 (en) 1996-10-16
NL300046I2 (en) 2001-12-01
DE69028884D1 (en) 1996-11-21
GR3022085T3 (en) 1997-03-31
CA2035900C (en) 2000-01-11
AU6052390A (en) 1991-02-06
LV12000B (en) 1998-06-20
IL95057A0 (en) 1991-06-10
PT94680A (en) 1991-04-18
RU2105812C1 (en) 1998-02-27
WO1991000909A1 (en) 1991-01-24
FI105047B (en) 2000-05-31
HUT56884A (en) 1991-10-28
HU906046D0 (en) 1991-07-29
LV12000A (en) 1998-03-20
NO2001018I2 (en) 2006-05-01
PT94680B (en) 1997-04-30
NL300046I1 (en) 2001-09-03
JPH04501807A (en) 1992-04-02
IL95057A (en) 1997-07-13
HU215948B (en) 1999-03-29
MC2145A1 (en) 1992-02-18
AU636637B2 (en) 1993-05-06

Similar Documents

Publication Publication Date Title
CA2035900A1 (en) Protein having urate oxidase activity, recombinant gene coding for this protein, expression vector, microorganisms and transformed cells
DE59812730D1 (en) Microorganisms and processes for the fermentative production of L-cysteine, L-cystine, N-acetyl-serine or thiazolinedin derivatives
GR3019043T3 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
AU600253B2 (en) Expression of eucaryotic proteins
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
DE59913343D1 (en) Highly active alkaline phosphatase
BG50281A3 (en) METHOD FOR OBTAINING A RECOMBINANT DNA EXPRESSION VECTOR
AU7949991A (en) Cloned n-methylhydantoinase
AU1778988A (en) Novel fibrinolytic enzymes
AU7508694A (en) Novel tyrosine kinase
AU3082795A (en) Hard and soft wheat thioredoxins h, homologous proteins, dna fragments coding for said proteins and methods for preparing same
ATE346941T1 (en) PROTEIN DISULFIDE ISOMERASE GENE OF A METHYLOTROPHIC YEAST STRAIN
Litvak et al. DNA polymerase and DNA synthesis in wheat embryo mitochondria
Jakoby et al. Nomenclature of multiple forms of enzymes recommendations (1976)
ES2023538A6 (en) METHOD FOR OBTAINING AND PURIFYING THE CARBOXYL-TERMINAL FRAGMENT OF THE DNA POLYMERASE I OF -i(STREPTOCOCCUS PNEUNOMIAE).

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry